Amgen’s version, Amgevita, was the first adalimumab biosimilar to be approved by the European Commission (EC). David Reese, executive vice president of R&D at Amgen, said: “The launch of ...
Biosimilar adalimumab is backed by robust science ... Nonetheless, the pricing of Humira biosimilars from Sandoz, Amgen (Amgevita and Solymbi), Boehringer Ingelheim (Cyltezo), Samsung Bioepis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback